Category: Global Regulation

  • Korea Tightening Vape Regulations in 2026

    Korea Tightening Vape Regulations in 2026

    South Korea will classify synthetic nicotine e-cigarettes as tobacco under a revised Tobacco Business Act that takes effect on April 24, 2026, marking the first change to the legal definition of tobacco since 1988. The amendment closes a regulatory loophole that previously excluded synthetic nicotine products, bringing them under existing tobacco controls following government studies that found such products contain carcinogens and other harmful substances.

    Under the new framework, synthetic nicotine e-cigarettes will be subject to mandatory health warning images and text on packaging, stricter advertising rules, and use bans in smoke-free areas such as schools, hospitals, and government buildings. Flavor-based marketing aimed at young people will be prohibited, and online sales, social media promotion, external store displays, and sponsorships will be banned. Sales will be limited to designated tobacco retail outlets.

    Additional measures include tighter controls on vending machines, requiring adult verification systems, and banning machines in educational protection zones from February 2026. Health authorities said compliance monitoring manuals are already in place for manufacturers and importers.

  • Hong Kong Expands No-Smoking Areas, Doubles Fines

    Hong Kong Expands No-Smoking Areas, Doubles Fines

    Hong Kong will double fines for smoking offences to HK$3,000 ($385) and expand no-smoking areas from January 1, 2026, under the Tobacco Control Legislation (Amendment) Ordinance 2025, the Department of Health said. The new rules ban smoking within three meters of entrances and exits to childcare centers, schools, hospitals, residential care homes, and specified clinics, and prohibit smoking while queuing, including at public transport boarding areas and outside designated premises.

    Authorities said enforcement and public education efforts have been stepped up at border checkpoints, tourist sites, and transport hubs. The measures are part of a phased rollout of tougher tobacco controls, following earlier steps such as higher penalties for illicit cigarettes and a ban on sales to under-18s, with a further ban on using alternative smoking products like e-cigarettes in public places set to take effect on April 30, 2026.

  • Kyrgyzstan Bans Vape Imports

    Kyrgyzstan Bans Vape Imports

    The Kyrgyz Cabinet of Ministers approved a six-month temporary ban on the import of electronic cigarettes and their cartridges, according to a new government decree. The restriction will take effect 15 days after its official publication and is aimed at curbing nicotine addiction and reducing the growing use of e-cigarettes, particularly among young people. Authorities said the rapid spread of electronic cigarettes among youth in recent years has raised serious public health concerns, prompting the move to limit the uncontrolled entry of these products into the country.

    The decision aligns Kyrgyzstan with a broader regional trend, as Kazakhstan imposed a full ban on the sale and advertising of e-cigarettes in June 2024, while Uzbekistan introduced restrictions on their distribution starting in November 2025.

  • France Suspends Decree Banning Nicotine Pouches

    France Suspends Decree Banning Nicotine Pouches

    France’s Council of State suspended a government decree that would have banned the manufacture, sale, and export of nicotine pouches from April 2026, pending a full legal review. The decision follows a challenge by EVLB Group, which argued the decree violated EU free trade rules and gave manufacturers insufficient time to reorganize operations. The court agreed, ruling that companies should have been granted a longer transition period and suspending the decree until a final judgment, expected by June 2026.

    The Council of State noted, however, that the marketing of nicotine pouches is already prohibited under France’s Public Health Code outside pharmaceutical use, meaning the suspension is unlikely to change current retail conditions. The Health Ministry said it takes note of the ruling and emphasized that the ban on marketing and possession remains in effect for now, while industry groups welcomed the pause as an opportunity for a more thorough review of the products.

  • Bangladesh Approves Strict New Tobacco-Control Measures

    Bangladesh Approves Strict New Tobacco-Control Measures

    Bangladesh’s Council of Advisers approved the Smoking and Tobacco Products Usage (Control) (Amendment) Ordinance 2025 on December 24, paving the way for stricter tobacco control measures. The ordinance proposes a ban on the use, production, and marketing of emerging tobacco products, including e-cigarettes, heated tobacco products, and “similar items,” while expanding the definition of tobacco products to include nicotine pouches.

    The amended law also prohibits the use of all tobacco products in public places and public transport, with designated smoking areas subject to government directives. Advertising, promotion, and display of tobacco products—including online marketing—would be fully banned, and enforcement powers strengthened through expanded definitions of public places and transport.

    In addition, the ordinance increases mandatory health warnings on tobacco packaging from 50% to 75% of the pack surface. The government said the measures are aimed at significantly reducing tobacco use and strengthening public health protection nationwide.

  • FDA Hosting PMTA Roundtable for Small ENDS Manufacturers

    FDA Hosting PMTA Roundtable for Small ENDS Manufacturers

    The U.S. Food and Drug Administration issued a Federal Register notice announcing a roundtable discussion with small tobacco product manufacturers on February 10, 2026, from 9 a.m. to 5 p.m. ET. The meeting will focus on gathering feedback on premarket tobacco product application (PMTA) submissions for electronic nicotine delivery systems (ENDS) and is open for public viewing.

    Participation in the roundtable is limited to 30 representatives from manufacturers with fewer than 350 employees who have previously submitted an ENDS PMTA, including applications that are still pending with the FDA. The discussion will give small manufacturers an opportunity to share their experiences and perspectives on the PMTA process, including challenges related to product characterization, manufacturing controls, pharmacological studies, adult benefit research, and toxicological assessments.

    Manufacturers interested in participating as panelists must send an email to register by January 27, 2026, with selections made on a rolling basis and limited to one representative per company. Non-panelists and members of the public will be able to watch the roundtable virtually via information posted on the FDA’s Center for Tobacco Products website. The meeting will be recorded and captioned.

  • Irish Retailers Lose Fight Against ‘Irrational’ License Fees

    Irish Retailers Lose Fight Against ‘Irrational’ License Fees

    A retailers’ group failed in a High Court challenge against Ireland’s new licensing fees of up to €1,800 for selling tobacco and nicotine products. Justice Rory Mulcahy ruled that the former health minister acted lawfully in setting the fees under the Public Health (Tobacco Products and Nicotine Inhaling Products) Act 2023, finding the charges were justified on public health grounds and not arbitrary.

    The new regime, effective from February, replaces a one-off €50 registration fee with renewable annual fees of €1,800 for tobacco and nicotine products, €1,000 for tobacco only, or €800 for nicotine products only. The court rejected claims that the fees were irrational or disproportionately harmful to small retailers, noting that discouraging tobacco sales would not make the regulations unlawful.

  • Philippines Requires Licenses for Vape Products With Health Claims

    Philippines Requires Licenses for Vape Products With Health Claims

    The Philippines’ Food and Drug Administration (FDA) mandated that all establishments selling vaporized nicotine and non-nicotine products (VNNPs) and novel tobacco products (NTPs) with medicinal or therapeutic claims must secure a License to Operate. Under Advisory 2025-1487, manufacturers, importers, distributors, wholesalers, and retailers are required to apply for licenses as pharmaceutical establishments.

    The FDA also said such products must be registered as pharmaceutical products through the Center for Drug Regulation and Research. The agency urged stakeholders to comply, citing the need to ensure the safety, efficacy, and quality of vape and novel tobacco products making health-related claims.

  • FDA Authorizes Six on! PLUS Nicotine Pouch Products

    FDA Authorizes Six on! PLUS Nicotine Pouch Products

    The U.S. FDA authorized the marketing of six nicotine pouch products from Helix Innovations LLC under the on! PLUS brand through the premarket tobacco product application (PMTA) pathway.

    These authorizations mark the first decisions from a pilot program launched in September to streamline the review process for nicotine pouch applications while maintaining the agency’s rigorous scientific standards. Authorized products include mint, tobacco, and wintergreen flavors in 6 mg and 9 mg nicotine strengths. The FDA noted that these products contain lower levels of harmful constituents compared with other smokeless tobacco products and do not contain measurable levels of several carcinogens linked to oral cancer.

    “While today’s actions permit these specific nicotine pouch products to be legally marketed in the U.S. to adults 21 and older, it does not mean these tobacco products are safe, nor are they ‘FDA approved,’” FDA said in a statement.  

    All packaging will feature certified child-resistant cans.

  • Georgia Wants Declining Smoking Rate Down Quicker

    Georgia Wants Declining Smoking Rate Down Quicker

    Georgia’s National Center for Disease Control and Public Health presented new findings from studies conducted under the Global Tobacco Surveillance System, finding 25.4% of adults and 14% of young people in the country use tobacco products. Despite the gradual decline in overall consumption, Health Minister Mikheil Sarjveladze said reducing tobacco use remains a key public health priority and stressed the importance of evidence-based policymaking in shaping effective tobacco control measures. While welcoming the downward trend, the NCDC noted that stronger action is still needed to further reduce tobacco use.

    The nationwide surveys, carried out between 2023 and 2025, have already informed Georgia’s National Tobacco Control Strategy for 2026–2030.